Stegostoma fasciatum isolate 6-17 chromosome 20, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039246.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
adducin 3 (gamma) a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X2
adducin 3 (gamma) a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
adducin 3 (gamma) a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
survival motor neuron domain containing 1
survival of motor neuron-related-splicing factor 30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
structural maintenance of chromosomes protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SHOC2 leucine rich repeat scaffold protein, transcript variant X1
SHOC2 leucine rich repeat scaffold protein, transcript variant X2
VPS10 domain-containing receptor SorCS3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 58
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cilia- and flagella-associated protein 58
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
PDZ domain containing 7a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PDZ domain containing 7a, transcript variant X2
PDZ domain-containing protein 7a isoform X1
PDZ domain-containing protein 7a isoform X2
leucine zipper, putative tumor suppressor 2a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine zipper, putative tumor suppressor 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine zipper, putative tumor suppressor 2a, transcript variant X10
leucine zipper, putative tumor suppressor 2a, transcript variant X1
leucine zipper, putative tumor suppressor 2a, transcript variant X2
leucine zipper, putative tumor suppressor 2a, transcript variant X6
leucine zipper, putative tumor suppressor 2a, transcript variant X3
leucine zipper, putative tumor suppressor 2a, transcript variant X8
leucine zipper, putative tumor suppressor 2a, transcript variant X9
leucine zipper, putative tumor suppressor 2a, transcript variant X5
leucine zipper, putative tumor suppressor 2a, transcript variant X11
leucine zipper, putative tumor suppressor 2a, transcript variant X12
leucine zipper, putative tumor suppressor 2a, transcript variant X13
leucine zipper, putative tumor suppressor 2a, transcript variant X14
leucine zipper putative tumor suppressor 2a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial ribosomal protein L43, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial ribosomal protein L43, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
39S ribosomal protein L43, mitochondrial
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Gb
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
SMC5-SMC6 complex localization factor protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
major facilitator superfamily domain containing 13A
suppressor of fused homolog (Drosophila)
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X3
uncharacterized LOC125461756, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125461756, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WW domain binding protein 1-like a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
WW domain binding protein 1-like a isoform X1
WW domain binding protein 1-like a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WW domain binding protein 1-like a isoform X3
WW domain binding protein 1-like a, transcript variant X2
WW domain binding protein 1-like a isoform X2
WW domain binding protein 1-like a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WW domain binding protein 1-like a isoform X4
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
steroid 17-alpha-hydroxylase/17,20 lyase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
steroid 17-alpha-hydroxylase/17,20 lyase isoform X2
steroid 17-alpha-hydroxylase/17,20 lyase isoform X1
steroid 17-alpha-hydroxylase/17,20 lyase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
metal transporter CNNM2-like, transcript variant X1
metal transporter CNNM2-like, transcript variant X2
metal transporter CNNM2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
glutamic-oxaloacetic transaminase 1, soluble
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125462019, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125462019, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 25 member 28, transcript variant X1
solute carrier family 25 member 28, transcript variant X6
solute carrier family 25 member 28, transcript variant X5
solute carrier family 25 member 28, transcript variant X2
solute carrier family 25 member 28, transcript variant X4
solute carrier family 25 member 28, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
CREB3 regulatory factor-like, transcript variant X6
CREB3 regulatory factor-like, transcript variant X4
CREB3 regulatory factor-like, transcript variant X3
CREB3 regulatory factor-like, transcript variant X5
CREB3 regulatory factor-like, transcript variant X1
CREB3 regulatory factor-like, transcript variant X8
CREB3 regulatory factor-like, transcript variant X10
CREB3 regulatory factor-like, transcript variant X14
CREB3 regulatory factor-like, transcript variant X12
CREB3 regulatory factor-like, transcript variant X7
CREB3 regulatory factor-like, transcript variant X13
CREB3 regulatory factor-like, transcript variant X9
CREB3 regulatory factor-like, transcript variant X2
CREB3 regulatory factor-like, transcript variant X11
CREB3 regulatory factor-like, transcript variant X15
pyridine nucleotide-disulphide oxidoreductase domain 2, transcript variant X2
pyridine nucleotide-disulphide oxidoreductase domain 2, transcript variant X1
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2
uncharacterized protein LOC641500 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC641500 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC641500 homolog, transcript variant X2
uncharacterized protein LOC641500 homolog, transcript variant X4
uncharacterized protein zgc:123010 isoform X3
uncharacterized protein zgc:123010 isoform X1
uncharacterized protein zgc:123010 isoform X2
uncharacterized protein zgc:123010 isoform X4
lysyl oxidase-like 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
lysyl oxidase-like 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
R3H domain and coiled-coil containing 1-like
coiled-coil domain-containing protein R3HCC1L
cartilage acidic protein 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cartilage acidic protein 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
4-hydroxy-2-oxoglutarate aldolase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
4-hydroxy-2-oxoglutarate aldolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
4-hydroxy-2-oxoglutarate aldolase, mitochondrial isoform X2
4-hydroxy-2-oxoglutarate aldolase, mitochondrial isoform X1
ankyrin repeat domain 2 (stretch responsive muscle), transcript variant X2
ankyrin repeat domain 2 (stretch responsive muscle), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain-containing protein 2 isoform X2
ankyrin repeat domain-containing protein 2 isoform X1
zinc finger protein 436-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 436-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
MMS19 homolog, cytosolic iron-sulfur assembly component, transcript variant X2
MMS19 homolog, cytosolic iron-sulfur assembly component, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MMS19 nucleotide excision repair protein homolog isoform X2
MMS19 nucleotide excision repair protein homolog isoform X1
zinc finger DHHC-type palmitoyltransferase 16b, transcript variant X5
zinc finger DHHC-type palmitoyltransferase 16b, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 16b, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 16b, transcript variant X3
zinc finger DHHC-type palmitoyltransferase 16b, transcript variant X4
palmitoyltransferase ZDHHC16B isoform X1
palmitoyltransferase ZDHHC16B isoform X2
exosome component 1, transcript variant X1
exosome component 1, transcript variant X3
exosome component 1, transcript variant X2
exosome complex component CSL4 isoform X3
exosome complex component CSL4 isoform X2
exosome complex component CSL4 isoform X1
uncharacterized wu:fc17b08, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized wu:fc17b08, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein wu:fc17b08 isoform X1
uncharacterized wu:fc17b08, transcript variant X3
uncharacterized protein wu:fc17b08 isoform X2
uncharacterized wu:fc17b08, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized wu:fc17b08, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized wu:fc17b08, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein wu:fc17b08 isoform X3
uncharacterized wu:fc17b08, transcript variant X7
uncharacterized wu:fc17b08, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein wu:fc17b08 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4-kinase type 2 alpha
phosphatidylinositol 4-kinase type 2-alpha
cell division cycle 25 homolog d, transcript variant X1
cell division cycle 25 homolog d, transcript variant X2
cell division cycle 25 homolog d, transcript variant X3
cell division cycle 25 homolog d, transcript variant X5
cell division cycle 25 homolog d isoform X1
cell division cycle 25 homolog d isoform X2
cell division cycle 25 homolog d isoform X3
cell division cycle 25 homolog d isoform X5
cell division cycle 25 homolog d, transcript variant X4
cell division cycle 25 homolog d isoform X4
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 7 isoform X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 7 isoform X2
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X1
cytochrome c oxidase assembly protein COX15 homolog, transcript variant X2
cytochrome c oxidase assembly protein COX15 homolog isoform X1
cytochrome c oxidase assembly protein COX15 homolog isoform X2
cutC copper transporter homolog (E. coli), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cutC copper transporter homolog (E. coli), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cutC copper transporter homolog (E. coli), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cutC copper transporter homolog (E. coli), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
copper homeostasis protein cutC homolog isoform X1
copper homeostasis protein cutC homolog isoform X2
ATP-binding cassette sub-family C member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
canalicular multispecific organic anion transporter 1
dynamin binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynamin binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dynamin binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynamin binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Kv channel-interacting protein 2, transcript variant X4
Kv channel-interacting protein 2, transcript variant X9
Kv channel-interacting protein 2, transcript variant X7
Kv channel-interacting protein 2, transcript variant X6
Kv channel-interacting protein 2, transcript variant X10
Kv channel-interacting protein 2, transcript variant X1
Kv channel-interacting protein 2, transcript variant X5
Kv channel-interacting protein 2, transcript variant X2
Kv channel-interacting protein 2, transcript variant X3
Kv channel-interacting protein 2, transcript variant X8
Kv channel-interacting protein 2 isoform X8
Kv channel-interacting protein 2 isoform X3
Kv channel-interacting protein 2 isoform X6
Kv channel-interacting protein 2 isoform X5
Kv channel-interacting protein 2 isoform X9
Kv channel-interacting protein 2 isoform X4
Kv channel-interacting protein 2 isoform X1
Kv channel-interacting protein 2 isoform X7
Kv channel-interacting protein 2 isoform X2
armadillo like helical domain containing 3, transcript variant X1
armadillo-like helical domain-containing protein 3 isoform X1
armadillo like helical domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
armadillo-like helical domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
LIM domain binding 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
LIM domain binding 1a, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LIM domain-binding protein 1-A isoform X3
LIM domain-binding protein 1-A isoform X1
LIM domain-binding protein 1-A isoform X2
LIM domain-binding protein 1-A isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
polymerase (DNA directed), lambda, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polymerase (DNA directed), lambda, transcript variant X2
polymerase (DNA directed), lambda, transcript variant X1
deleted in primary ciliary dyskinesia homolog (mouse)
F-box and WD repeat domain containing 4, transcript variant X2
F-box and WD repeat domain containing 4, transcript variant X3
F-box and WD repeat domain containing 4, transcript variant X1
F-box/WD repeat-containing protein 4 isoform X2
F-box/WD repeat-containing protein 4 isoform X3
F-box/WD repeat-containing protein 4 isoform X1
fibroblast growth factor 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibroblast growth factor 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 8-like isoform X2
fibroblast growth factor 8-like isoform X1
uncharacterized LOC125461954, transcript variant X3
uncharacterized LOC125461954, transcript variant X2
uncharacterized LOC125461954, transcript variant X5
uncharacterized LOC125461954, transcript variant X1
uncharacterized LOC125461954, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125461954, transcript variant X7
uncharacterized LOC125461954, transcript variant X6
uncharacterized LOC125461954, transcript variant X8
uncharacterized protein LOC125461954 isoform X3
uncharacterized protein LOC125461954 isoform X2
uncharacterized protein LOC125461954 isoform X1
uncharacterized protein LOC125461954 isoform X4
solute carrier family 2, facilitated glucose transporter member 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear apoptosis inducing factor 1, transcript variant X1
nuclear apoptosis inducing factor 1, transcript variant X2
nuclear apoptosis-inducing factor 1 isoform X1
nuclear apoptosis-inducing factor 1 isoform X2
transcription factor LBX1-like, transcript variant X1
transcription factor LBX1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor LBX1-like isoform X1
transcription factor LBX1-like isoform X2
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like isoform X1
kazal-type serine protease inhibitor domain-containing protein 1-like isoform X2
T cell leukemia homeobox 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
T cell leukemia homeobox 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
T cell leukemia homeobox 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
T-cell leukemia homeobox protein 1 isoform X2
T-cell leukemia homeobox protein 1 isoform X1
inactive pancreatic lipase-related protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 5
ATP synthase membrane subunit k, transcript variant X1
ATP synthase membrane subunit k, transcript variant X2
ATP synthase membrane subunit DAPIT, mitochondrial
programmed cell death 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
programmed cell death 11, transcript variant X2
programmed cell death 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
inositol 1,4,5-trisphosphate receptor-interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor-interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor-interacting protein
cilia and flagella associated protein 43, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia and flagella associated protein 43, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia and flagella associated protein 43, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 43 isoform X1
cilia- and flagella-associated protein 43 isoform X2
cilia- and flagella-associated protein 43 isoform X3
cilia and flagella associated protein 43, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 43 isoform X4
SWI5-dependent homologous recombination repair protein 1, transcript variant X2
SWI5-dependent homologous recombination repair protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
swi5-dependent recombination DNA repair protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
STN1 subunit of CST complex, transcript variant X2
STN1 subunit of CST complex, transcript variant X1
STE20-like kinase a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
STE20-like kinase a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
STE20-like kinase a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
STE20-like serine/threonine-protein kinase isoform X1
STE20-like serine/threonine-protein kinase isoform X2
STE20-like serine/threonine-protein kinase isoform X3
Rho GTPase activating protein 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Rho GTPase activating protein 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho GTPase activating protein 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho GTPase activating protein 19, transcript variant X4
rho GTPase-activating protein 19 isoform X1
rho GTPase-activating protein 19 isoform X3
rho GTPase-activating protein 19 isoform X4
rho GTPase-activating protein 19 isoform X2
5'-nucleotidase, cytosolic IIa, transcript variant X2
5'-nucleotidase, cytosolic IIa, transcript variant X3
5'-nucleotidase, cytosolic IIa, transcript variant X1
5'-nucleotidase, cytosolic IIa, transcript variant X4
5'-nucleotidase, cytosolic IIa isoform X2
5'-nucleotidase, cytosolic IIa isoform X1
5'-nucleotidase, cytosolic IIa isoform X3
polycomb group ring finger 6, transcript variant X2
polycomb group ring finger 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
polycomb group RING finger protein 6 isoform X2
polycomb group RING finger protein 6 isoform X1
aldehyde dehydrogenase 18 family, member A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
aldehyde dehydrogenase 18 family, member A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
delta-1-pyrroline-5-carboxylate synthase isoform X2
delta-1-pyrroline-5-carboxylate synthase isoform X1
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 1 isoform X2
ectonucleoside triphosphate diphosphohydrolase 1 isoform X1
ectonucleoside triphosphate diphosphohydrolase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ectonucleoside triphosphate diphosphohydrolase 1 isoform X3
peroxisome proliferator-activated receptor gamma coactivator-related protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
SH3 and PX domains 2Aa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
SH3 and PX domain-containing protein 2A isoform X1
SH3 and PX domains 2Aa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SH3 and PX domains 2Aa, transcript variant X2
SH3 and PX domain-containing protein 2A isoform X3
SH3 and PX domain-containing protein 2A isoform X2
SH3 and PX domains 2Aa, transcript variant X4
SH3 and PX domain-containing protein 2A isoform X4
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X2
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glycerol-3-phosphate acyltransferase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X3
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X2
glycerol-3-phosphate acyltransferase 1, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
eukaryotic translation initiation factor 3, subunit 10 (theta)
eukaryotic translation initiation factor 3 subunit A
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00413
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CDK2-associated and cullin domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
prolactin-releasing peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 204 member A, transcript variant X1
family with sequence similarity 204 member A, transcript variant X2
rab11 family-interacting protein 2, transcript variant X1
rab11 family-interacting protein 2, transcript variant X2
rab11 family-interacting protein 2 isoform X1
rab11 family-interacting protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
potassium channel, subfamily K, member 18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
V-type proton ATPase subunit B, brain isoform-like, transcript variant X1
V-type proton ATPase subunit B, brain isoform-like, transcript variant X2
V-type proton ATPase subunit B, brain isoform-like isoform X1
V-type proton ATPase subunit B, brain isoform-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heat shock protein 12A, transcript variant X5
heat shock protein 12A, transcript variant X6
heat shock protein 12A, transcript variant X3
heat shock 70 kDa protein 12A isoform X3
heat shock protein 12A, transcript variant X1
heat shock protein 12A, transcript variant X4
heat shock protein 12A, transcript variant X2
heat shock 70 kDa protein 12A isoform X1
heat shock 70 kDa protein 12A isoform X4
heat shock 70 kDa protein 12A isoform X2
heat shock 70 kDa protein 12A isoform X5
pancreatic lipase-related protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 172
GDNF family receptor alpha-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
GDNF family receptor alpha-1-like isoform X1
GDNF family receptor alpha-1-like, transcript variant X2
GDNF family receptor alpha-1-like isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
TruB pseudouridine (psi) synthase family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TruB pseudouridine (psi) synthase family member 1, transcript variant X1
FHF complex subunit HOOK interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
actin binding LIM protein 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
actin binding LIM protein 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
actin binding LIM protein 1b, transcript variant X4
actin binding LIM protein 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
actin binding LIM protein 1b, transcript variant X5
actin filament associated protein 1-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
actin filament-associated protein 1-like 2
von Willebrand factor A domain containing 2, transcript variant X2
von Willebrand factor A domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 2 isoform X2
von Willebrand factor A domain-containing protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 186, transcript variant X1
coiled-coil domain-containing protein 186, transcript variant X3
coiled-coil domain-containing protein 186, transcript variant X2
coiled-coil domain-containing protein 186 isoform X1
coiled-coil domain-containing protein 186 isoform X2
coiled-coil domain-containing protein 186 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae), transcript variant X3
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae), transcript variant X4
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae), transcript variant X5
DNA cross-link repair 1A protein isoform X2
DNA cross-link repair 1A protein isoform X1
DNA cross-link repair 1A protein isoform X3
pleckstrin homology domain-containing family S member 1-like
caspase 7, apoptosis-related cysteine peptidase, transcript variant X2
caspase 7, apoptosis-related cysteine peptidase, transcript variant X1
basic salivary proline-rich protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
basic salivary proline-rich protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
basic salivary proline-rich protein 4-like isoform X2
basic salivary proline-rich protein 4-like isoform X1
hyaluronan-binding protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
hyaluronan-binding protein 2-like, transcript variant X2
transcription factor 7 like 2, transcript variant X11
transcription factor 7 like 2, transcript variant X4
transcription factor 7 like 2, transcript variant X2
transcription factor 7 like 2, transcript variant X8
transcription factor 7 like 2, transcript variant X7
transcription factor 7 like 2, transcript variant X1
transcription factor 7 like 2, transcript variant X3
transcription factor 7 like 2, transcript variant X9
transcription factor 7 like 2, transcript variant X6
transcription factor 7 like 2, transcript variant X5
transcription factor 7 like 2, transcript variant X13
transcription factor 7 like 2, transcript variant X12
transcription factor 7 like 2, transcript variant X14
transcription factor 7 like 2, transcript variant X10
transcription factor 7 like 2, transcript variant X15
transcription factor 7 like 2, transcript variant X16
transcription factor 7-like 2 isoform X11
transcription factor 7-like 2 isoform X8
transcription factor 7-like 2 isoform X7
transcription factor 7-like 2 isoform X4
transcription factor 7-like 2 isoform X2
transcription factor 7-like 2 isoform X13
transcription factor 7-like 2 isoform X12
transcription factor 7-like 2 isoform X3
transcription factor 7-like 2 isoform X14
transcription factor 7-like 2 isoform X9
transcription factor 7-like 2 isoform X6
transcription factor 7-like 2 isoform X10
transcription factor 7-like 2 isoform X5
transcription factor 7-like 2 isoform X1
transcription factor 7-like 2 isoform X16
transcription factor 7-like 2 isoform X15
transcription factor 7 like 2, transcript variant X18
transcription factor 7 like 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X31
transcription factor 7 like 2, transcript variant X19
transcription factor 7 like 2, transcript variant X23
transcription factor 7 like 2, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor 7 like 2, transcript variant X28
transcription factor 7 like 2, transcript variant X25
transcription factor 7-like 2 isoform X29
transcription factor 7-like 2 isoform X28
transcription factor 7-like 2 isoform X27
transcription factor 7-like 2 isoform X22
transcription factor 7-like 2 isoform X18
transcription factor 7-like 2 isoform X17
transcription factor 7 like 2, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor 7-like 2 isoform X19
transcription factor 7 like 2, transcript variant X29
transcription factor 7 like 2, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor 7-like 2 isoform X26
transcription factor 7-like 2 isoform X25
transcription factor 7 like 2, transcript variant X22
transcription factor 7 like 2, transcript variant X20
transcription factor 7 like 2, transcript variant X27
transcription factor 7-like 2 isoform X24
transcription factor 7-like 2 isoform X21
transcription factor 7-like 2 isoform X23
transcription factor 7-like 2 isoform X20
vesicle transport through interaction with t-SNAREs 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vesicle transport through interaction with t-SNAREs 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
vesicle transport through interaction with t-SNAREs 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
vesicle transport through interaction with t-SNAREs 1A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
vesicle transport through interaction with t-SNAREs homolog 1A isoform X2
vesicle transport through interaction with t-SNAREs homolog 1A isoform X1
vesicle transport through interaction with t-SNAREs homolog 1A isoform X4
vesicle transport through interaction with t-SNAREs homolog 1A isoform X3
zinc finger DHHC-type palmitoyltransferase 6
acyl-CoA synthetase long chain family member 5, transcript variant X2
acyl-CoA synthetase long chain family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
EF-hand calcium-binding domain-containing protein 6-like
thioredoxin-dependent peroxide reductase, mitochondrial
U6 snRNA-associated Sm-like protein LSm1
G protein-coupled receptor kinase 5-like, transcript variant X1
G protein-coupled receptor kinase 5-like isoform X1
G protein-coupled receptor kinase 5-like, transcript variant X2
G protein-coupled receptor kinase 5-like isoform X2
regulator of G-protein signaling 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TIA1 cytotoxic granule-associated RNA binding protein-like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BAG family molecular chaperone regulator 3
inositol polyphosphate-5-phosphatase F, transcript variant X1
phosphatidylinositide phosphatase SAC2 isoform X1
inositol polyphosphate-5-phosphatase F, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
inositol polyphosphate-5-phosphatase F, transcript variant X2
phosphatidylinositide phosphatase SAC2 isoform X2
inositol polyphosphate-5-phosphatase F, transcript variant X3
phosphatidylinositide phosphatase SAC2 isoform X3
minichromosome maintenance complex binding protein
mini-chromosome maintenance complex-binding protein
phospholipid phosphatase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipid phosphatase 4, transcript variant X3
phospholipid phosphatase 4, transcript variant X2
WD repeat domain 11, transcript variant X1
WD repeat domain 11, transcript variant X3
WD repeat-containing protein 11 isoform X1
WD repeat-containing protein 11 isoform X3
WD repeat domain 11, transcript variant X2
WD repeat-containing protein 11 isoform X2
fibroblast growth factor receptor 2-like, transcript variant X9
fibroblast growth factor receptor 2-like, transcript variant X7
fibroblast growth factor receptor 2-like, transcript variant X11
fibroblast growth factor receptor 2-like, transcript variant X10
fibroblast growth factor receptor 2-like, transcript variant X8
fibroblast growth factor receptor 2-like, transcript variant X13
fibroblast growth factor receptor 2-like, transcript variant X12
fibroblast growth factor receptor 2-like, transcript variant X2
fibroblast growth factor receptor 2-like, transcript variant X1
fibroblast growth factor receptor 2-like, transcript variant X4
fibroblast growth factor receptor 2-like, transcript variant X3
fibroblast growth factor receptor 2-like, transcript variant X6
fibroblast growth factor receptor 2-like isoform X8
fibroblast growth factor receptor 2-like isoform X7
fibroblast growth factor receptor 2-like isoform X4
fibroblast growth factor receptor 2-like isoform X3
fibroblast growth factor receptor 2-like isoform X2
fibroblast growth factor receptor 2-like isoform X1
fibroblast growth factor receptor 2-like isoform X6
fibroblast growth factor receptor 2-like, transcript variant X5
fibroblast growth factor receptor 2-like isoform X5
arginyl-tRNA--protein transferase 1, transcript variant X2
arginyl-tRNA--protein transferase 1, transcript variant X3
arginyl-tRNA--protein transferase 1, transcript variant X8
arginyl-tRNA--protein transferase 1, transcript variant X5
arginyl-tRNA--protein transferase 1, transcript variant X4
arginyl-tRNA--protein transferase 1, transcript variant X1
arginyl-tRNA--protein transferase 1, transcript variant X7
arginyl-tRNA--protein transferase 1 isoform X7
arginyl-tRNA--protein transferase 1 isoform X2
arginyl-tRNA--protein transferase 1 isoform X4
arginyl-tRNA--protein transferase 1 isoform X3
arginyl-tRNA--protein transferase 1 isoform X1
arginyl-tRNA--protein transferase 1 isoform X6
arginyl-tRNA--protein transferase 1, transcript variant X6
arginyl-tRNA--protein transferase 1 isoform X5
NSE4 homolog A, SMC5-SMC6 complex component, transcript variant X1
non-structural maintenance of chromosomes element 4 homolog A isoform X1
NSE4 homolog A, SMC5-SMC6 complex component, transcript variant X2
non-structural maintenance of chromosomes element 4 homolog A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 1 isoform X1
pleckstrin homology domain-containing family A member 1 isoform X2
pleckstrin homology domain-containing family A member 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC570656 homolog
disintegrin and metalloproteinase domain-containing protein 9
zinc finger protein Pegasus-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein Pegasus-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger protein Pegasus-like, transcript variant X5
zinc finger protein Pegasus-like, transcript variant X4
zinc finger protein Pegasus-like, transcript variant X1
zinc finger protein Pegasus-like isoform X1
zinc finger protein Pegasus-like isoform X2
acyl-CoA dehydrogenase short/branched chain
short/branched chain specific acyl-CoA dehydrogenase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
carboxypeptidase X (M14 family), member 2
inactive carboxypeptidase-like protein X2
carbohydrate sulfotransferase 15-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
carbohydrate sulfotransferase 15-like, transcript variant X4
carbohydrate sulfotransferase 15-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
carbohydrate sulfotransferase 15-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
carbohydrate sulfotransferase 15-like, transcript variant X2
carbohydrate sulfotransferase 15-like, transcript variant X6
carbohydrate sulfotransferase 15-like, transcript variant X7
carbohydrate sulfotransferase 15-like, transcript variant X8
ornithine aminotransferase, mitochondrial
NK1 transcription factor related 2-like,a
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X1
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X3
phospholysine phosphohistidine inorganic pyrophosphate phosphatase, transcript variant X2
phospholysine phosphohistidine inorganic pyrophosphate phosphatase isoform X2
family with sequence similarity 53 member B, transcript variant X11
family with sequence similarity 53 member B, transcript variant X10
family with sequence similarity 53 member B, transcript variant X7
family with sequence similarity 53 member B, transcript variant X5
family with sequence similarity 53 member B, transcript variant X1
family with sequence similarity 53 member B, transcript variant X4
family with sequence similarity 53 member B, transcript variant X6
family with sequence similarity 53 member B, transcript variant X2
family with sequence similarity 53 member B, transcript variant X3
family with sequence similarity 53 member B, transcript variant X9
family with sequence similarity 53 member B, transcript variant X8
family with sequence similarity 53 member B, transcript variant X12
EEF1A lysine methyltransferase 2, transcript variant X3
EEF1A lysine methyltransferase 2, transcript variant X5
EEF1A lysine methyltransferase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
EEF1A lysine methyltransferase 2, transcript variant X1
EEF1A lysine methyltransferase 2, transcript variant X4
EEF1A lysine methyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
EEF1A lysine methyltransferase 2 isoform X3
EEF1A lysine methyltransferase 2 isoform X5
EEF1A lysine methyltransferase 2 isoform X1
EEF1A lysine methyltransferase 2 isoform X2
EEF1A lysine methyltransferase 2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
4-hydroxyphenylpyruvate dioxygenase-like
4-hydroxyphenylpyruvate dioxygenase-like protein
ubiquitin thioesterase ZRANB1, transcript variant X3
ubiquitin thioesterase ZRANB1, transcript variant X2
ubiquitin thioesterase ZRANB1, transcript variant X1
ubiquitin thioesterase ZRANB1, transcript variant X6
ubiquitin thioesterase ZRANB1, transcript variant X5
ubiquitin thioesterase ZRANB1, transcript variant X4
ubiquitin thioesterase ZRANB1 isoform X1
ubiquitin thioesterase ZRANB1 isoform X2
C-terminal-binding protein 2, transcript variant X4
C-terminal-binding protein 2, transcript variant X5
C-terminal-binding protein 2, transcript variant X3
C-terminal-binding protein 2, transcript variant X2
C-terminal-binding protein 2, transcript variant X1
C-terminal-binding protein 2, transcript variant X6
uncharacterized protein LOC125461811 isoform X1
uncharacterized protein LOC125461811 isoform X2
erythroid differentiation regulatory factor 1, transcript variant X1
erythroid differentiation regulatory factor 1, transcript variant X2
erythroid differentiation regulatory factor 1, transcript variant X3
erythroid differentiation-related factor 1 isoform X1
erythroid differentiation-related factor 1 isoform X2
erythroid differentiation-related factor 1 isoform X3
uroporphyrinogen III synthase, transcript variant X5
uroporphyrinogen III synthase, transcript variant X3
uroporphyrinogen III synthase, transcript variant X2
uroporphyrinogen III synthase, transcript variant X1
uroporphyrinogen III synthase, transcript variant X4
uroporphyrinogen-III synthase isoform X2
uroporphyrinogen-III synthase isoform X1
BRCA2 and CDKN1A interacting protein, transcript variant X2
BRCA2 and CDKN1A interacting protein, transcript variant X1
DEAH (Asp-Glu-Ala-His) box polypeptide 32a, transcript variant X3
DEAH (Asp-Glu-Ala-His) box polypeptide 32a, transcript variant X2
DEAH (Asp-Glu-Ala-His) box polypeptide 32a, transcript variant X1
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 32a isoform X3
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 32a isoform X2
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 32a isoform X1
fibronectin type III and ankyrin repeat domains 1
fibronectin type 3 and ankyrin repeat domains protein 1
disintegrin and metalloproteinase domain-containing protein 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome 20 C10orf90 homolog, transcript variant X4
chromosome 20 C10orf90 homolog, transcript variant X2
chromosome 20 C10orf90 homolog, transcript variant X3
chromosome 20 C10orf90 homolog, transcript variant X1
(E2-independent) E3 ubiquitin-conjugating enzyme FATS isoform X1
chromosome 20 C10orf90 homolog, transcript variant X5
(E2-independent) E3 ubiquitin-conjugating enzyme FATS isoform X2
dedicator of cytokinesis 1, transcript variant X3
dedicator of cytokinesis 1, transcript variant X1
dedicator of cytokinesis 1, transcript variant X2
dedicator of cytokinesis protein 1 isoform X1
dedicator of cytokinesis protein 1 isoform X2
dedicator of cytokinesis protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type Ea, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tyrosine phosphatase receptor type Ea, transcript variant X7
protein tyrosine phosphatase receptor type Ea, transcript variant X4
protein tyrosine phosphatase receptor type Ea, transcript variant X1
protein tyrosine phosphatase receptor type Ea, transcript variant X3
receptor-type tyrosine-protein phosphatase epsilon isoform X1
receptor-type tyrosine-protein phosphatase epsilon isoform X2
protein tyrosine phosphatase receptor type Ea, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tyrosine phosphatase receptor type Ea, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase epsilon isoform X3
uncharacterized LOC125461810, transcript variant X2
uncharacterized LOC125461810, transcript variant X3
uncharacterized LOC125461810, transcript variant X1
marker of proliferation Ki-67, transcript variant X2
marker of proliferation Ki-67, transcript variant X3
marker of proliferation Ki-67, transcript variant X1
marker of proliferation Ki-67, transcript variant X4
proliferation marker protein Ki-67 isoform X1
proliferation marker protein Ki-67 isoform X3
proliferation marker protein Ki-67 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
methylated-DNA--protein-cysteine methyltransferase
EBF transcription factor 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
EBF transcription factor 3a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
EBF transcription factor 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
EBF transcription factor 3a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
EBF transcription factor 3a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transcription elongation regulator 1 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation regulator 1-like protein
protein phosphatase 2, regulatory subunit B, delta, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X2
protein phosphatase 2, regulatory subunit B, delta, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X1
protein phosphatase 2, regulatory subunit B, delta, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X3
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3
Janus kinase and microtubule interacting protein 3, transcript variant X4
Janus kinase and microtubule interacting protein 3, transcript variant X1
Janus kinase and microtubule interacting protein 3, transcript variant X2
Janus kinase and microtubule interacting protein 3, transcript variant X5
Janus kinase and microtubule interacting protein 3, transcript variant X7
Janus kinase and microtubule interacting protein 3, transcript variant X6
Janus kinase and microtubule interacting protein 3, transcript variant X8
Janus kinase and microtubule interacting protein 3, transcript variant X3
Janus kinase and microtubule interacting protein 3, transcript variant X9
Janus kinase and microtubule interacting protein 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X11
Janus kinase and microtubule interacting protein 3, transcript variant X16
Janus kinase and microtubule interacting protein 3, transcript variant X12
Janus kinase and microtubule interacting protein 3, transcript variant X13
Janus kinase and microtubule interacting protein 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Janus kinase and microtubule interacting protein 3, transcript variant X14
janus kinase and microtubule-interacting protein 3 isoform X1
janus kinase and microtubule-interacting protein 3 isoform X2
janus kinase and microtubule-interacting protein 3 isoform X4
janus kinase and microtubule-interacting protein 3 isoform X3
janus kinase and microtubule-interacting protein 3 isoform X5
janus kinase and microtubule-interacting protein 3 isoform X6
janus kinase and microtubule-interacting protein 3 isoform X7
janus kinase and microtubule-interacting protein 3 isoform X8
janus kinase and microtubule-interacting protein 3 isoform X13
janus kinase and microtubule-interacting protein 3 isoform X9
janus kinase and microtubule-interacting protein 3 isoform X10
janus kinase and microtubule-interacting protein 3 isoform X12
janus kinase and microtubule-interacting protein 3 isoform X11
dihydropyrimidinase like 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dihydropyrimidinase like 4, transcript variant X1
dihydropyrimidinase-related protein 4 isoform X1
dihydropyrimidinase-related protein 4 isoform X2
dihydropyrimidinase like 4, transcript variant X3
dihydropyrimidinase-related protein 4 isoform X3
serine/threonine-protein kinase 32C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
serine/threonine-protein kinase 32C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase 32C, transcript variant X4
serine/threonine-protein kinase 32C, transcript variant X5
serine/threonine-protein kinase 32C, transcript variant X3
serine/threonine-protein kinase 32C, transcript variant X6
serine/threonine-protein kinase 32C isoform X2
serine/threonine-protein kinase 32C isoform X1
serine/threonine-protein kinase 32C isoform X3
serine/threonine-protein kinase 32C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
serine/threonine-protein kinase 32C, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase 32C isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
leucine-rich repeat-containing protein 27-like
inositol polyphosphate-5-phosphatase A, transcript variant X2
inositol polyphosphate-5-phosphatase A, transcript variant X1
inositol polyphosphate-5-phosphatase A isoform X1
inositol polyphosphate-5-phosphatase A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins
cilia- and flagella-associated protein 46
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X1
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X3
kinase non-catalytic C-lobe domain-containing protein 1 isoform X1
kinase non-catalytic C-lobe domain-containing protein 1 isoform X2
kinase non-catalytic C-lobe domain-containing protein 1, transcript variant X4
kinase non-catalytic C-lobe domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
homeobox protein vex1-like, transcript variant X1
homeobox protein vex1-like, transcript variant X3
homeobox protein vex1-like, transcript variant X2
homeobox protein vex1-like, transcript variant X7
homeobox protein vex1-like, transcript variant X8
homeobox protein vex1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
homeobox protein vex1-like, transcript variant X6
homeobox protein vex1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X10
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X13
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X8
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X1
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X3
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X14
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X6
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X4
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X18
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X9
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X15
heparan sulfate glucosamine 3-O-sulfotransferase 1-like, transcript variant X19
heparan sulfate glucosamine 3-O-sulfotransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 518A, transcript variant X2
zinc finger protein 518A, transcript variant X1
zinc finger protein 518A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein CC2D2B-like
RNA/RNP complex-1-interacting phosphatase-like
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated
TATA-binding protein-associated factor 172
cytoplasmic polyadenylation element binding protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cytoplasmic polyadenylation element binding protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic polyadenylation element binding protein 3, transcript variant X3
cytoplasmic polyadenylation element binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytoplasmic polyadenylation element binding protein 3, transcript variant X1
cytoplasmic polyadenylation element binding protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 3 isoform X5
cytoplasmic polyadenylation element-binding protein 3 isoform X3
cytoplasmic polyadenylation element-binding protein 3 isoform X2
cytoplasmic polyadenylation element-binding protein 3 isoform X1
cytoplasmic polyadenylation element-binding protein 3 isoform X4
membrane-associated ring finger (C3HC4) 5, transcript variant X2
E3 ubiquitin-protein ligase MARCH5 isoform X2
membrane-associated ring finger (C3HC4) 5, transcript variant X1
E3 ubiquitin-protein ligase MARCH5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
hematopoietically-expressed homeobox protein hhex
exocyst complex component 6-like, transcript variant X1
exocyst complex component 6-like, transcript variant X4
exocyst complex component 6-like, transcript variant X2
exocyst complex component 6-like, transcript variant X6
exocyst complex component 6-like isoform X1
exocyst complex component 6-like isoform X2
exocyst complex component 6-like isoform X4
exocyst complex component 6-like isoform X6
exocyst complex component 6-like, transcript variant X3
exocyst complex component 6-like, transcript variant X10
exocyst complex component 6-like, transcript variant X5
exocyst complex component 6-like, transcript variant X7
exocyst complex component 6-like, transcript variant X8
exocyst complex component 6-like isoform X3
exocyst complex component 6-like isoform X5
exocyst complex component 6-like isoform X9
exocyst complex component 6-like isoform X7
exocyst complex component 6-like, transcript variant X9
exocyst complex component 6-like isoform X8
cytochrome P450 26C1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytochrome P450 26C1-like, transcript variant X2
cytochrome P450 26A1, transcript variant X3
cytochrome P450 26A1, transcript variant X1
cytochrome P450 26A1, transcript variant X2
centrosomal protein 55 like, transcript variant X1
centrosomal protein 55 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
centrosomal protein 55 like, transcript variant X3
centrosomal protein of 55 kDa isoform X1
centrosomal protein of 55 kDa isoform X2
centrosomal protein of 55 kDa isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
retinol binding protein 4, plasma, transcript variant X2
retinol binding protein 4, plasma, transcript variant X1
phosphodiesterase 6C, cGMP-specific, cone, alpha prime, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6C, cGMP-specific, cone, alpha prime, transcript variant X3
phosphodiesterase 6C, cGMP-specific, cone, alpha prime, transcript variant X2
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' isoform X1
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' isoform X3
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' isoform X2
phosphodiesterase 6C, cGMP-specific, cone, alpha prime, transcript variant X5
phosphodiesterase 6C, cGMP-specific, cone, alpha prime, transcript variant X4
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' isoform X4
cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
leucine-rich, glioma inactivated 1b, transcript variant X3
leucine-rich, glioma inactivated 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich, glioma inactivated 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
leucine-rich, glioma inactivated 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich glioma-inactivated protein 1b isoform X1
leucine-rich glioma-inactivated protein 1b isoform X2
leucine-rich glioma-inactivated protein 1b isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phospholipase C, epsilon 1, transcript variant X1
phospholipase C, epsilon 1, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 isoform X2
phospholipase C, epsilon 1, transcript variant X3
phospholipase C, epsilon 1, transcript variant X4
phospholipase C, epsilon 1, transcript variant X5
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 isoform X3
NOC3-like DNA replication regulator, transcript variant X2
nucleolar complex protein 3 homolog isoform X2
NOC3-like DNA replication regulator, transcript variant X1
nucleolar complex protein 3 homolog isoform X1
TBC1 domain family, member 12b, transcript variant X3
TBC1 domain family, member 12b, transcript variant X2
TBC1 domain family, member 12b, transcript variant X1
TBC1 domain family, member 12b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fibroblast growth factor-binding protein 3-like
poly [ADP-ribose] polymerase tankyrase-2-like, transcript variant X1
poly [ADP-ribose] polymerase tankyrase-2-like, transcript variant X3
poly [ADP-ribose] polymerase tankyrase-2-like, transcript variant X2
poly [ADP-ribose] polymerase tankyrase-2-like isoform X3
poly [ADP-ribose] polymerase tankyrase-2-like isoform X2
poly [ADP-ribose] polymerase tankyrase-2-like isoform X1
uncharacterized LOC125461730, transcript variant X2
uncharacterized LOC125461730, transcript variant X1
protein phosphatase 1, regulatory subunit 3Cb
protein phosphatase 1 regulatory subunit 3C-B
probable E3 ubiquitin-protein ligase HECTD2
polycomb group ring finger 5b, transcript variant X1
polycomb group ring finger 5b, transcript variant X2
polycomb group ring finger 5b, transcript variant X3
ankyrin repeat domain-containing protein 1-like
ribonuclease P/MRP 30 subunit, transcript variant X1
ribonuclease P/MRP 30 subunit, transcript variant X2
ribonuclease P/MRP 30 subunit, transcript variant X3
ribonuclease P protein subunit p30 isoform X1
ribonuclease P/MRP 30 subunit, transcript variant X4
ribonuclease P protein subunit p30 isoform X2
kinesin family member 20Bb, transcript variant X1
kinesin family member 20Bb, transcript variant X3
kinesin family member 20Bb, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pantothenate kinase 1, transcript variant X1
pantothenate kinase 1, transcript variant X2
pantothenate kinase 1, transcript variant X4
pantothenate kinase 1, transcript variant X3
monocarboxylate transporter 12-like, transcript variant X1
monocarboxylate transporter 12-like isoform X1
monocarboxylate transporter 12-like, transcript variant X2
monocarboxylate transporter 12-like isoform X2
interferon-induced protein with tetratricopeptide repeats 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: interferon-induced protein with tetratricopeptide repeats 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X2
interferon-induced protein with tetratricopeptide repeats 5-like, transcript variant X1
interferon-induced protein with tetratricopeptide repeats 5-like isoform X1
interferon-induced protein with tetratricopeptide repeats 5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
interferon-induced protein with tetratricopeptide repeats 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: interferon-induced protein with tetratricopeptide repeats 1-like
interferon-induced protein with tetratricopeptide repeats 1B-like
apobec1 complementation factor, transcript variant X1
apobec1 complementation factor, transcript variant X3
apobec1 complementation factor, transcript variant X2
apobec1 complementation factor, transcript variant X4
apobec1 complementation factor, transcript variant X5
APOBEC1 complementation factor isoform X1
APOBEC1 complementation factor isoform X3
APOBEC1 complementation factor isoform X2
APOBEC1 complementation factor isoform X4
APOBEC1 complementation factor isoform X5
N-acylsphingosine amidohydrolase 2, transcript variant X2
N-acylsphingosine amidohydrolase 2, transcript variant X1
N-acylsphingosine amidohydrolase 2, transcript variant X3
sphingomyelin synthase 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X9
sphingomyelin synthase 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sphingomyelin synthase 1b, transcript variant X4
sphingomyelin synthase 1b, transcript variant X8
phosphatidylcholine:ceramide cholinephosphotransferase 1
multiple inositol-polyphosphate phosphatase 1b, transcript variant X2
multiple inositol-polyphosphate phosphatase 1b, transcript variant X1
multiple inositol polyphosphate phosphatase 1b isoform X1
multiple inositol polyphosphate phosphatase 1b isoform X2
3'-phosphoadenosine 5'-phosphosulfate synthase 2b
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2b
ATPase family AAA domain containing 1b, transcript variant X2
ATPase family AAA domain containing 1b, transcript variant X1
ATPase family AAA domain containing 1b, transcript variant X3
outer mitochondrial transmembrane helix translocase isoform X2
outer mitochondrial transmembrane helix translocase isoform X1
outer mitochondrial transmembrane helix translocase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
renalase, FAD-dependent amine oxidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
renalase, FAD-dependent amine oxidase, transcript variant X2
gastric triacylglycerol lipase isoform X1
gastric triacylglycerol lipase isoform X2
ankyrin repeat domain-containing protein 22
STAM binding protein-like 1, transcript variant X4
STAM binding protein-like 1, transcript variant X1
STAM binding protein-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
STAM binding protein-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
STAM binding protein-like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 6-like, transcript variant X2
tumor necrosis factor receptor superfamily member 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 6-like
dickkopf WNT signaling pathway inhibitor 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protocadherin-related 15b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protocadherin-related 15b, transcript variant X1
CDGSH iron-sulfur domain-containing protein 1
transcription factor A, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcription factor A, mitochondrial, transcript variant X2
transcription factor A, mitochondrial, transcript variant X1
transcription factor A, mitochondrial isoform X1
transcription factor A, mitochondrial isoform X2
transcription factor A, mitochondrial isoform X3
protein bicaudal C homolog 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein bicaudal C homolog 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein bicaudal C homolog 1-like isoform X1
protein bicaudal C homolog 1-like isoform X2
protein bicaudal C homolog 1-like, transcript variant X3
protein bicaudal C homolog 1-like isoform X3
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X1
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X2
phytanoyl-CoA hydroxylase-interacting protein-like isoform X1
phytanoyl-CoA 2-hydroxylase interacting protein-like b, transcript variant X3
phytanoyl-CoA hydroxylase-interacting protein-like isoform X2
family with sequence similarity 13 member C, transcript variant X2
family with sequence similarity 13 member C, transcript variant X3
family with sequence similarity 13 member C, transcript variant X4
family with sequence similarity 13 member C, transcript variant X5
family with sequence similarity 13 member C, transcript variant X6
family with sequence similarity 13 member C, transcript variant X7
family with sequence similarity 13 member C, transcript variant X1
family with sequence similarity 13 member C, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
coiled-coil domain-containing protein 6b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin-dependent kinase 1, transcript variant X5
cyclin-dependent kinase 1, transcript variant X1
cyclin-dependent kinase 1, transcript variant X2
cyclin-dependent kinase 1, transcript variant X3
cyclin-dependent kinase 1, transcript variant X4
Rho related BTB domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Rho related BTB domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho related BTB domain containing 1, transcript variant X4
Rho related BTB domain containing 1, transcript variant X2
rho-related BTB domain-containing protein 1 isoform X1
Rho related BTB domain containing 1, transcript variant X5
rho-related BTB domain-containing protein 1 isoform X2
transmembrane protein 26-like, transcript variant X2
transmembrane protein 26-like, transcript variant X1
transmembrane protein 26-like isoform X1
transmembrane protein 26-like isoform X2
ciliary associated calcium binding coiled-coil 1, transcript variant X1
ciliary associated calcium binding coiled-coil 1, transcript variant X2
ciliary-associated calcium-binding coiled-coil protein 1 isoform X1
ciliary-associated calcium-binding coiled-coil protein 1 isoform X2
AT-rich interaction domain 5B, transcript variant X1
AT-rich interaction domain 5B, transcript variant X2
AT-rich interactive domain-containing protein 5B isoform X1
AT-rich interactive domain-containing protein 5B isoform X2
AT-rich interaction domain 5B, transcript variant X3
AT-rich interactive domain-containing protein 5B isoform X3
AT-rich interaction domain 5B, transcript variant X4
AT-rich interactive domain-containing protein 5B isoform X4
AT-rich interaction domain 5B, transcript variant X5
AT-rich interactive domain-containing protein 5B isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nuclear receptor binding factor 2b, transcript variant X1
nuclear receptor binding factor 2b, transcript variant X4
nuclear receptor binding factor 2b, transcript variant X3
nuclear receptor binding factor 2b, transcript variant X2
nuclear receptor-binding factor 2b isoform X1
nuclear receptor-binding factor 2b isoform X2
nuclear receptor-binding factor 2b isoform X3
jumonji domain containing 1Cb, transcript variant X1
jumonji domain containing 1Cb, transcript variant X2
probable JmjC domain-containing histone demethylation protein 2C isoform X1
probable JmjC domain-containing histone demethylation protein 2C isoform X2
receptor accessory protein 3b, transcript variant X1
receptor expression-enhancing protein 3 isoform X1
receptor accessory protein 3b, transcript variant X2
receptor accessory protein 3b, transcript variant X3
receptor expression-enhancing protein 3 isoform X2
receptor expression-enhancing protein 3 isoform X3
solute carrier family 22 member 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 22 member 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
solute carrier family 22 member 15, transcript variant X2
solute carrier family 22 member 15, transcript variant X4
solute carrier family 22 member 15 isoform X1
solute carrier family 22 member 15 isoform X2
solute carrier family 22 member 15 isoform X4
solute carrier family 22 member 15 isoform X3
leucine-rich repeat transmembrane neuronal protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 3-like, transcript variant X2
leucine-rich repeat transmembrane neuronal protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 3-like isoform X1
leucine-rich repeat transmembrane neuronal protein 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DnaJ (Hsp40) homolog, subfamily C, member 12
NAD-dependent protein deacetylase sirtuin-1 isoform X1
NAD-dependent protein deacetylase sirtuin-1 isoform X2
cytochrome c oxidase subunit 5B, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cytochrome c oxidase subunit 5B, mitochondrial
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X1
probable E3 ubiquitin-protein ligase HERC4
HECT and RLD domain containing E3 ubiquitin protein ligase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
polycystic kidney disease 2-like 1 protein
protein phosphatase 1K, mitochondrial-like
broad substrate specificity ATP-binding cassette transporter ABCG2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
helicase, lymphoid specific, transcript variant X1
helicase, lymphoid specific, transcript variant X4
helicase, lymphoid specific, transcript variant X2
helicase, lymphoid specific, transcript variant X3
helicase, lymphoid specific, transcript variant X5
uncharacterized protein LOC100535981 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein si:ch211-250c4.3
RUN and FYVE domain containing 2, transcript variant X4
RUN and FYVE domain containing 2, transcript variant X5
RUN and FYVE domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RUN and FYVE domain containing 2, transcript variant X6
RUN and FYVE domain containing 2, transcript variant X1
RUN and FYVE domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
RUN and FYVE domain containing 2, transcript variant X3
RUN and FYVE domain containing 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RUN and FYVE domain-containing protein 2 isoform X4
RUN and FYVE domain-containing protein 2 isoform X5
RUN and FYVE domain-containing protein 2 isoform X6
RUN and FYVE domain-containing protein 2 isoform X1
RUN and FYVE domain-containing protein 2 isoform X2
RUN and FYVE domain-containing protein 2 isoform X3
RUN and FYVE domain-containing protein 2 isoform X7
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein H3-like isoform X2
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein H3-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein H3-like isoform X1
heterogeneous nuclear ribonucleoprotein H3-like isoform X3
DNA replication helicase/nuclease 2, transcript variant X2
DNA replication helicase/nuclease 2, transcript variant X3
DNA replication helicase/nuclease 2, transcript variant X1
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X3
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
eukaryotic translation initiation factor 4E-like
solute carrier family 25 member 16, transcript variant X1
solute carrier family 25 member 16, transcript variant X3
graves disease carrier protein isoform X1
graves disease carrier protein isoform X3
solute carrier family 25 member 16, transcript variant X2
solute carrier family 25 member 16, transcript variant X4
graves disease carrier protein isoform X2
graves disease carrier protein isoform X4
selenoprotein U 1a, transcript variant X1
selenoprotein U 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 152 Proteins
tachykinin receptor 2, transcript variant X2
tachykinin receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tachykinin receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 157 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 123 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
ATP-dependent RNA helicase SUPV3L1, mitochondrial
vacuolar protein sorting-associated protein 26A
kinesin family binding protein, transcript variant X1
kinesin family binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cell division cycle and apoptosis regulator 1, transcript variant X2
cell division cycle and apoptosis regulator 1, transcript variant X1
cell division cycle and apoptosis regulator protein 1 isoform X1
cell division cycle and apoptosis regulator protein 1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00607
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns